Anti-inflammatory Agents: Emerging evidence supports the use of IL-6 inhibitors and NSAIDs to target inflammation-related pathways that exacerbate both anxiety and metabolic dysfunction [159]. The gene discussed is IL6; the disease is Anxiety.